Cargando…

Practice management for elderly patients with breast cancer; Findings from a survey by the Japan Breast Cancer Study Group

Information on patterns of clinical care for elderly breast cancer patients is lacking. The aims of this study are two-fold, firstly, to clarify daily practice treatments for elderly breast cancer patients in Japan, and secondly, to plan a prospective clinical trial to address unresolved clinical qu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sawaki, Masataka, Tamura, Kenji, Shimomura, Akihiko, Taki, Yumiko, Nagashima, Fumio, Iwata, Hiroji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nagoya University 2018
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995731/ https://www.ncbi.nlm.nih.gov/pubmed/29915439 http://dx.doi.org/10.18999/nagjms.80.2.217

Ejemplares similares

Real-world treatment patterns of subsequent therapy after palbociclib in patients with advanced breast cancer in Japan
por: Sawaki, Masataka, et al.
Publicado: (2023)

Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer
por: Masuda, Norikazu, et al.
Publicado: (2021)

Rainbow of KIBOU (ROK) study: a Breast Cancer Survivor Cohort in Japan
por: Mizota, Yuri, et al.
Publicado: (2017)

The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition
por: Inokuchi, Masafumi, et al.
Publicado: (2019)

Correction to: The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition
por: Inokuchi, Masafumi, et al.
Publicado: (2021)

Bone Scan Index predicts skeletal-related events in patients with metastatic breast cancer
por: Idota, Ai, et al.
Publicado: (2016)

Impact of intrinsic subtype on predicting axillary lymph node metastasis in breast cancer
por: SAWAKI, MASATAKA, et al.
Publicado: (2014)

A case of radiation-associated angiosarcoma after breast cancer
por: Horisawa, Nanae, et al.
Publicado: (2018)

Circulating tumor cells detection in tumor draining vein of breast cancer patients
por: Hattori, Masaya, et al.
Publicado: (2019)

Treatments for elderly cancer patients and reforms to social security systems in Japan
por: Nagashima, Fumio, et al.
Publicado: (2022)

Cost-Effectiveness of Trastuzumab With or Without Chemotherapy as Adjuvant Therapy in HER2-Positive Elderly Breast Cancer Patients: A Randomized, Open-Label Clinical Trial, the RESPECT Trial
por: Takumoto, Yuki, et al.
Publicado: (2022)

Phase 1 study of oral selective estrogen receptor degrader (SERD) amcenestrant (SAR439859), in Japanese women with ER-positive and HER2-negative advanced breast cancer (AMEERA-2)
por: Tamura, Kenji, et al.
Publicado: (2023)

JS2-1 Multidisciplinary cooperation for elderly cancer patients receiving chemotherapy in Japan
por: Nagashima, Fumio
Publicado: (2022)

Trastuzumab emtansine in the treatment of HER2-positive metastatic breast cancer in Japanese patients
por: Sawaki, Masataka
Publicado: (2014)

Evaluation of the Role of Axillary Lymph Node Fine-Needle Aspiration Cytology in Early Breast Cancer With or Without Neoadjuvant Chemotherapy
por: Takatsuka, Daiki, et al.
Publicado: (2023)

Time to Chemotherapy for Patients With Estrogen Receptor-Positive Breast Cancer and Cyclin-Dependent Kinase 4 and 6 Inhibitor Use
por: Endo, Yuka, et al.
Publicado: (2022)

Amyloid tumor of the breast
por: Mori, Makiko, et al.
Publicado: (2019)

A case of giant cell tumor of the breast, clinically suspected as malignant breast tumor
por: Terada, Mitsuo, et al.
Publicado: (2019)

Single-dose trastuzumab monotherapy achieved pathological complete response (pCR) in a patient with HER2-positive breast cancer: a case report
por: Isogai, Ayaka, et al.
Publicado: (2023)

Study protocol for a nationwide questionnaire survey of physical activity among breast cancer survivors in Japan
por: Shimizu, Yoichi, et al.
Publicado: (2020)

The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition
por: Uematsu, Takayoshi, et al.
Publicado: (2019)

No Association of the 5′Promoter Region Polymorphism of CYP17 with Breast Cancer Risk in Japan
por: Hamajima, Nobuyuki, et al.
Publicado: (2000)

Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition
por: Uematsu, Takayoshi, et al.
Publicado: (2021)

Interaction of the Effects of Alcohol Drinking and Polymorphisms in Alcohol-Metabolizing Enzymes on the Risk of Female Breast Cancer in Japan
por: Kawase, Takakazu, et al.
Publicado: (2009)

Recent Improvement in the Long-term Survival of Breast Cancer Patients by Age and Stage in Japan
por: Yoshimura, Akiyo, et al.
Publicado: (2018)

Clinicopathological features of male patients with breast cancer based on a nationwide registry database in Japan
por: Shimomura, Akihiko, et al.
Publicado: (2022)

The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2018 edition
por: Yamauchi, Chikako, et al.
Publicado: (2019)

Functions of Breast Cancer Predisposition Genes: Implications for Clinical Management
por: Yoshimura, Akiyo, et al.
Publicado: (2022)

Correction to: The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2018 edition
por: Yamauchi, Chikako, et al.
Publicado: (2021)

Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130)
por: Iwata, Hiroji, et al.
Publicado: (2019)

Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site
por: Kodaira, Makoto, et al.
Publicado: (2018)

Clinicopathological features of breast cancer without mammographic findings suggesting malignancy
por: Nakamura, Mei, et al.
Publicado: (2020)

Corrigendum to: Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130)
por: Iwata, Hiroji, et al.
Publicado: (2020)

A systematic literature review of prognostic factors in patients with HR+/HER2− advanced breast cancer in Japan
por: Hattori, Masaya, et al.
Publicado: (2021)

Brain metastasis-related microRNAs in patients with advanced breast cancer
por: Sato, Jun, et al.
Publicado: (2019)

Comorbid insomnia among breast cancer survivors and its prediction using machine learning: a nationwide study in Japan
por: Ueno, Taro, et al.
Publicado: (2021)

EARLY PREDICTION OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED BREAST CANCER USING MRI
por: KAWAMURA, MARIKO, et al.
Publicado: (2011)

TERT promoter hotspot mutations in breast cancer
por: Shimoi, Tatsunori, et al.
Publicado: (2017)

An overview of the Japan Breast Cancer Research Group (JBCRG) activities
por: Ohno, Shinji, et al.
Publicado: (2013)

Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study
por: Hattori, Masaya, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u13tt2togf5jq6lto6kj1l317b